Joel Martin
- Ophthalmology top 1%
- Retinal Diseases and Treatments 2
- Immunology and Allergy top 5%
- Otorhinolaryngology top 5%
- Dermatology top 5%
- Dermatology and Skin Diseases 2
-
- Angiogenesis and VEGF in Cancer 3
- Receptor Mechanisms and Signaling 2
-
- IL-33, ST2, and ILC Pathways 2
-
- Herpesvirus Infections and Treatments 2
-
- Electrolyte and hormonal disorders 2
-
- Asthma and respiratory diseases 2
Joel Martin
21 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Ophthalmology 600
- Immunology and Allergy 158
- Radiology, Nuclear Medicine and Imaging 548
- Otorhinolaryngology 57
- Dermatology 107
Countries citing papers authored by Joel Martin
This map shows the geographic impact of Joel Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Martin more than expected).
Fields of papers citing papers by Joel Martin
This network shows the impact of papers produced by Joel Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Martin. The network helps show where Joel Martin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joel Martin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 62 | |
| 2 | Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammationbreakdown → | 2019 | 330 |
| 3 | 2019 | 23 | |
| 4 | Wild Type and Mutant Retinoschisin Subunits Co-assemble When Expressed in the Same Cells | 2018 | 1 |
| 5 | 2018 | 4 | |
| 6 | 2014 | 42 | |
| 7 | Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabbreakdown → | 2012 | 823 |
| 8 | 2000 | 19 | |
| 9 | 1997 | 22 | |
| 10 | 1996 | 115 | |
| 11 | 1995 | 178 | |
| 12 | 1995 | 38 | |
| 13 | 1994 | 8 | |
| 14 | 1994 | 2 | |
| 15 | 1993 | 27 | |
| 16 | 1988 | 37 | |
| 17 | 1988 | 10 | |
| 18 | 1987 | 46 | |
| 19 | 1982 | 74 | |
| 20 | 1981 | 8 |
About Joel Martin
Joel Martin is a scholar working on Immunology, Dermatology and Ophthalmology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Dermatology and Skin Diseases (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Retinal Diseases and Treatments (2 papers), Herpesvirus Infections and Treatments (2 papers), Electrolyte and hormonal disorders (2 papers), Receptor Mechanisms and Signaling (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Ophthalmology (600 citations), Immunology and Allergy (158 citations) and Radiology, Nuclear Medicine and Imaging (548 citations). Joel Martin has collaborated with scholars based in United States and Denmark. Frequent co-authors include Ashique Rafique, Nicholas Papadopoulos, Neil Stahl, George D. Yancopoulos, Carol A. Miller, Ergang Shi, Stanley J. Wiegand, Erica Pyles, Qin Ruan and Michael Rosconi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Neuron and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.